Brittany L Dulmage, MD, FAAD
SESSIONS
F072 The Morbilliform Eruption: Differentiation and Treatment of Viral, Low-risk Drug, Severe Cutaneous Adverse Reactions, and GVHD
Mar 9, 2024
•
3:30 PM - 12:00 AM
•
Room 6C
DISCLOSURES
Azitra, Inc – Investigator(Grants/Research Funding); Hoth Therapeutics – Data Safety Monitoring Board(Honoraria); Novocure – Consultant (1099 relationship)(Honoraria); Revian LTD – Investigator(Grants/Research Funding);